Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001758363-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
15,000
Total Value
$460,134.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 2, 2026 | Sale | 12,709 | $30.47 | $387,243.23 | 674,198 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 2, 2026 | Sale | 2,191 | $31.79 | $69,651.89 | 672,007 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 2, 2026 | Sale | 100 | $32.39 | $3,239.00 | 671,907 | Direct | โ | View Details |